Paul Steven M

Number of records: 50
SEC FilingCompany/StockTrade DateTransactionSharesAvg. PriceTotal% HoldingsGain/Loss
18-Mar-24 4:30 PM
View: 
Karuna Therapeutics, Inc. (KRTX) 18-Mar-24Disposition 10,596$330.00$3,496,680.00(7%)
150.96K to 140.37K
18-Mar-24 4:30 PM
View: 
Karuna Therapeutics, Inc. (KRTX) 18-Mar-24Disposition 140,367$330.00$46,321,100.00(100%)
140.37K to 0
04-Mar-24 5:34 PM
View: 
Karuna Therapeutics, Inc. (KRTX) 04-Mar-24Gift 30,304----20%
150.96K to 181.27K
04-Mar-24 5:34 PM
View: 
Karuna Therapeutics, Inc. (KRTX) 04-Mar-24Gift 30,304----(17%)
181.27K to 150.96K
04-Mar-24 5:34 PM
View: 
Karuna Therapeutics, Inc. (KRTX) 01-Mar-24Gift 60,608----40%
150.96K to 211.57K
04-Mar-24 5:34 PM
View: 
Karuna Therapeutics, Inc. (KRTX) 01-Mar-24Gift 60,608----(29%)
211.57K to 150.96K
04-Mar-24 5:34 PM
View: 
Karuna Therapeutics, Inc. (KRTX) 29-Feb-24Acquisition (other) 47,378$315.18$14,932,600.0046%
103.58K to 150.96K
26-Feb-24 6:15 PM
View: 
Karuna Therapeutics, Inc. (KRTX) 23-Feb-24Option Exercise 31,518$19.03$599,675.0026%
119.44K to 150.96K
12-Feb-24 5:13 PM
View: 
Karuna Therapeutics, Inc. (KRTX) 09-Feb-24Payment of Exercise 804$317.14$254,981.00(< 1%)
120.25K to 119.44K
13-Feb-23 4:15 PM
View: 
Karuna Therapeutics, Inc. (KRTX) 09-Feb-23Grant 11,400----10%
108.85K to 120.25K
30-Nov-22 4:15 PM
View: 
Sage Therapeutics, Inc. (SAGE) 28-Nov-22Acquisition (other) 5$38.17$190.84< 1%
593.11K to 593.11K
13-Feb-23 4:15 PM
View: 
Karuna Therapeutics, Inc. (KRTX) 31-May-22Gift 106,485----98%
108.85K to 215.33K
13-Feb-23 4:15 PM
View: 
Karuna Therapeutics, Inc. (KRTX) 31-May-22Gift 106,485----(49%)
215.33K to 108.85K
13-Feb-23 4:15 PM
View: 
Karuna Therapeutics, Inc. (KRTX) 27-May-22Gift 106,485----98%
108.85K to 215.33K
13-Feb-23 4:15 PM
View: 
Karuna Therapeutics, Inc. (KRTX) 27-May-22Gift 106,485----(49%)
215.33K to 108.85K
05-Apr-22 4:05 PM
View: 
Alnylam Pharmaceuticals Inc. (ALNY) 01-Apr-22Option Exercise 15,000$11.33$169,950.001500%
1.0K to 16.0K
05-Apr-22 4:05 PM
View: 
Alnylam Pharmaceuticals Inc. (ALNY) 01-Apr-22Planned Option Sale 15,000$170.69$2,560,370.00(94%)
16.0K to 1.0K
12-Nov-21 4:53 PM
View: 
Sage Therapeutics, Inc. (SAGE) 09-Nov-21Acquisition (other) 1$43.36$43.36< 1%
514.57K to 514.57K
(2%)
18-Aug-21 7:43 PM
View: 
Karuna Therapeutics, Inc. (KRTX) 18-Aug-21Market Purchase 1,181$106.10$125,304.001%
107.67K to 108.85K
27%
18-Aug-21 7:43 PM
View: 
Karuna Therapeutics, Inc. (KRTX) 17-Aug-21Market Purchase 1,183$105.63$124,960.001%
106.48K to 107.67K
28%
22-Dec-20 4:02 PM
View: 
Alnylam Pharmaceuticals Inc. (ALNY) 18-Dec-20Option Exercise 15,000$9.30$139,500.001500%
1.0K to 16.0K
22-Dec-20 4:02 PM
View: 
Alnylam Pharmaceuticals Inc. (ALNY) 18-Dec-20Market Option Sale (Planned) 15,000$140.00$2,100,000.00(94%)
16.0K to 1.0K
30-Jun-20 4:25 PM
View: 
Karuna Therapeutics, Inc. (KRTX) 29-Jun-20Option Exercise 292,207$0.11$32,142.80274%
106.48K to 398.69K
30-Jun-20 4:25 PM
View: 
Karuna Therapeutics, Inc. (KRTX) 29-Jun-20Option Sale 292,207$103.50$30,243,400.00(73%)
398.69K to 106.48K
11-Feb-20 4:08 PM
View: 
Alnylam Pharmaceuticals Inc. (ALNY) 10-Feb-20Option Exercise 30,000$14.67$440,100.003000%
1.0K to 31.0K
11-Feb-20 4:08 PM
View: 
Alnylam Pharmaceuticals Inc. (ALNY) 10-Feb-20Market Option Sale (Planned) 30,000$130.00$3,900,000.00(97%)
31.0K to 1.0K
02-Jul-19 5:18 PM
View: 
Karuna Therapeutics, Inc. (KRTX) 02-Jul-19Conversion 96,485----965%
10.0K to 106.48K
01-Jul-19 8:26 PM
View: 
Karuna Therapeutics, Inc. (KRTX) 28-Jun-19Purchase 10,000$23.04$230,424.00100%
0 to 10.0K
22-Mar-19 4:22 PM
View: 
Sage Therapeutics, Inc. (SAGE) 21-Mar-19Market Sale (Planned) 7,879$161.04$1,268,820.00(1%)
654.71K to 646.83K
(8%)
20-Mar-19 8:47 PM
View: 
Sage Therapeutics, Inc. (SAGE) 20-Mar-19Market Sale (Planned) 56,646$161.29$9,136,580.00(3%)
1.69M to 1.63M
(8%)
20-Mar-19 8:47 PM
View: 
Sage Therapeutics, Inc. (SAGE) 18-Mar-19Market Sale (Planned) 3,775$161.05$607,977.00(< 1%)
1.69M to 1.69M
(8%)
05-Mar-19 10:00 PM
View: 
Sage Therapeutics, Inc. (SAGE) 01-Mar-19Market Sale (Planned) 2,600$161.00$418,600.00(< 1%)
1.04M to 1.04M
(8%)
27-Feb-19 5:48 PM
View: 
Sage Therapeutics, Inc. (SAGE) 25-Feb-19Gift 122,400----10%
1.27M to 1.39M
27-Feb-19 5:48 PM
View: 
Sage Therapeutics, Inc. (SAGE) 25-Feb-19Gift 122,400----(9%)
1.39M to 1.27M
27-Feb-19 5:48 PM
View: 
Sage Therapeutics, Inc. (SAGE) 25-Feb-19Market Sale (Planned) 2,000$161.00$322,000.00(< 1%)
1.27M to 1.27M
(8%)
20-Feb-19 7:55 AM
View: 
Sage Therapeutics, Inc. (SAGE) 19-Feb-19Market Sale (Planned) 1,543$161.62$249,373.00(< 1%)
1.18M to 1.18M
(8%)
20-Feb-19 7:55 AM
View: 
Sage Therapeutics, Inc. (SAGE) 15-Feb-19Market Sale (Planned) 49,461$161.02$7,964,210.00(4%)
1.23M to 1.18M
(8%)
20-Feb-19 7:55 AM
View: 
Sage Therapeutics, Inc. (SAGE) 01-Feb-19Gift 241,695----20%
1.23M to 1.47M
20-Feb-19 7:55 AM
View: 
Sage Therapeutics, Inc. (SAGE) 01-Feb-19Gift 241,695----(16%)
1.47M to 1.23M
14-Feb-19 10:00 PM
View: 
Sage Therapeutics, Inc. (SAGE) 26-Jul-18Gift 123,904----9%
1.4M to 1.52M
14-Feb-19 10:00 PM
View: 
Sage Therapeutics, Inc. (SAGE) 26-Jul-18Gift 123,904----(8%)
1.52M to 1.4M
14-Feb-19 10:00 PM
View: 
Sage Therapeutics, Inc. (SAGE) 13-Jul-18Gift 121,035----9%
1.4M to 1.52M
14-Feb-19 10:00 PM
View: 
Sage Therapeutics, Inc. (SAGE) 13-Jul-18Gift 121,035----(8%)
1.52M to 1.4M
08-Mar-18 4:02 PM
View: 
Sage Therapeutics, Inc. (SAGE) 06-Mar-18Market Sale (Planned) 58,139$172.00$9,999,910.00(8%)
690.85K to 632.71K
(1%)
17-Feb-17 5:57 PM
View: 
Sage Therapeutics, Inc. (SAGE) 31-Jan-17Acquisition (other) 2,174$3.15$6,848.10< 1%
688.68K to 690.85K
133%
05-Apr-16 7:33 PM
View: 
Sage Therapeutics, Inc. (SAGE) 23-Feb-16Gift 5,081----(< 1%)
4.77M to 4.76M
15-Jan-16 5:01 PM
View: 
Voyager Therapeutics, Inc. (VYGR) 14-Jan-16Market Purchase 10,000$14.07$140,690.001%
862.35K to 872.35K
(28%)
19-Nov-15 4:00 PM
View: 
Sigma-Aldrich Corp. (SIAL) 18-Nov-15Disposition 478$140.00$66,920.00(100%)
0.48K to 0
02-Sep-15 3:43 PM
View: 
Sage Therapeutics, Inc. (SAGE) 01-Sep-15Private Sale (Planned) 20,000$52.41$1,048,180.00(3%)
703.65K to 683.65K
04-Aug-15 11:32 AM
View: 
Sage Therapeutics, Inc. (SAGE) 03-Aug-15Private Sale (Planned) 20,000$67.08$1,341,690.00(3%)
723.65K to 703.65K